Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy

Detalles Bibliográficos
Autores principales: Abouhajar, Alaa, Alcock, Lisa, Bigirumurame, Theophile, Bradley, Penny, Brown, Laura, Campbell, Ian, Del Din, Silvia, Faitg, Julie, Falkous, Gavin, Gorman, Grainne S., Lakey, Rachel, McFarland, Robert, Newman, Jane, Rochester, Lynn, Ryan, Vicky, Smith, Hesther, Steel, Alison, Stefanetti, Renae J., Su, Huizhong, Taylor, Robert W., Thomas, Naomi J. P., Tuppen, Helen, Vincent, Amy E., Warren, Charlotte, Watson, Gillian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533513/
https://www.ncbi.nlm.nih.gov/pubmed/36199067
http://dx.doi.org/10.1186/s13063-022-06814-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533513/
https://www.ncbi.nlm.nih.gov/pubmed/36199067
http://dx.doi.org/10.1186/s13063-022-06814-8

Ejemplares similares